Join us online at COVERGENCE OCT 22-23
The University Tech/Startup Gap Fund and Accelerator Summit
- 20 in-depth gap fund/accelerator program reviews
- Breakout and group discussions on common challenges
- Corporate and Investor partnering panels
- Networking web-site and associated materials
A research team led by Xin Qi (associate professor of physiology and biophysics at the school of medicine) has been working for four years to develop drug treatments for HD, an inherited, chronic neurological disorder that causes brain cells to die, according to the release. The disorder, which has no known therapy to prevent or slow the disease, typically surfaces at age 40 and progresses until it is fatal about 10 to 20 years after diagnosis.
Based in Providence, Rhode Island, the Dr. Ralph and Marian Falk Medical Research Trust supports biomedical research with two programs: the Catalyst Research Award Program that provides seed funding to develop promising concepts, and the two-year Transformational Research Award to help researchers advance such concepts toward commercial development.